Hook Bolton
Mike Hook & Steve Bolton

Accutane Litigation

Hook-Bolton began the Accutane Litigation Project in the United States, assisting numerous law firms with their Accutane cases. In fact, Mike Hook has served as lead trial counsel in all Accutane Inflammatory Bowel Disease cases tried in the United States.

Our firm represents victims who have suffered IBD, including ulcerative colitis and Crohn's disease, as a result of using Accutane or its generic equivalent, Isotretinoin. Our clients have specifically won multiple lawsuits against the manufacturer of Accutane, Hoffman-LaRoche, Inc.

Please click here to view our verdicts and settlements.

What is Accutane?

Accutane (generic Isotretinoin) was an oral medication first developed by Hoffman-LaRoche, Inc. as a chemotherapy drug for certain types of cancer. Developers soon discovered its ability to treat nodular acne, the most severe form of acne.

Accutane was prescribed heavily from 1982 until 2009, when Hoffman-LaRoche discontinued the manufacture and distribution of the drug after studies tied it to a number of incurable inflammatory diseases and birth defects. However, after LaRoche’s patent expired in 2002, Isotretinoin (the generic version) became heavily produced under a wide variety of names and is still on the market today.

Damaging Side Effects

Though it does alleviate nodular acne, Accutane (Isotretinoin) has been directly linked to these serious and often permanent side effects:

These and many other Accutane side effects can be debilitating and life-threatening, and injuries can occur long after the drug is discontinued.

People who have suffered serious side effects from using Accutane (Isotretinoin) may be eligible to file a lawsuit. Our clients have won multiple lawsuits against Hoffman-LaRoche, Inc. Please click here to view our Accutane verdicts.

Because this section contains information about our firm's past results, the Florida Bar requires us to ask visitors to read and acknowledge the points below. If you would like to view this section, please check each box and click the "Accept" button.